http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110183418-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110183418-B |
| titleOfInvention | Sesquiterpene from mountain pepper plant root and separation method and application thereof |
| abstract | The invention discloses sesquiterpenes derived from the roots of a mountain pepper plant, and a separation method and application thereof. The structure of the sesquiterpene compound is shown in formula I, formula II and formula III. The 3 hemiterpene compounds are from the roots of the Lindera glauca (Lindera glauca) plant, can obviously inhibit the generation of NO in cells, particularly the generation of NO induced by LPS (LPS), and the IC (integrated circuit) of the compounds 50 Respectively 2.43 +/-0.27 mu M, 4.00 +/-1.15 mu M and 1.38 +/-0.30 mu M, has high safety to cells, can be prepared into anti-inflammatory drugs, and has great prospect in clinical application. |
| priorityDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.